Sangeetha M. Reddy
0000-0002-8401-1481
Publication & Citation Trends
Publications
0 total
Abstract LB-B008: cDC expansion and CD40 activation after immunogenic chemotherapy shift the breast tumor microenvironment toward functional T cell immunity and IL-12-dependent tumor control
Cited by 0
Semantic Scholar
846 Flt3 ligand and CD40 agonist immunotherapy activates mature dendritic cells enriched in regulatory features with opposing IL-12 and CCL22 programs in breast cancer
Cited by 0
Semantic Scholar
628 CD40 agonist-based triplet therapy engages intra-tumoral T cells to drive tumor control independent of lymph node trafficking in triple negative breast cancers
Cited by 0
Semantic Scholar
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
Cited by 8
Semantic Scholar
HIF-2-dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear Cell Renal Cell Carcinoma.
Cited by 4
Semantic Scholar
Abstract 6171: Flt3 ligand and CD40 agonist-based therapy in breast cancer promotes myeloid cell CXCL9 secretion and CD8 T cell recruitment but is not dependent on CXCL9 for efficacy
Cited by 0
Semantic Scholar
Abstract P3-09-16: SerpinE2 mediated cell competition during breast cancer metastasis to the liver
Cited by 0
Semantic Scholar
A comprehensive evaluation of de novo metastatic breast cancer trends by subtype from the Dallas Metastatic Cancer Study
Cited by 0
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(68)
Immunotherapy and Immune Responses
(22)
CAR-T cell therapy research
(14)
Cancer Genomics and Diagnostics
(13)
Monoclonal and Polyclonal Antibodies Research
(11)
Affiliations
Northwestern University
United States Nuclear Regulatory Commission
Shirley Ryan AbilityLab
The University of Texas MD Anderson Cancer Center
University of California, Los Angeles